SAN JOSE, Feb. 11, 2026 (GLOBE NEWSWIRE) — Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter, Year-End and Recent HighlightsNet revenue totaled $28.9 million in the fourth quarter, bringing revenue in 2025 to $119.5 million, a 5% increase over $113.7 million in 2024. Recurring revenue consisting of Tablo consumables and services was $22.5 million in the fourth quarter and grew 6% in 2025 to $88.7 million compared to $83.9 million in 2024. Gross margin expanded by nearly 600 basis points in the fourth quarter to 42.4% (42.9% on a non-GAAP basis). Gross margin for the year of 39.1% (39.6% on a non-GAAP...

Launch of Inspire V system complete with strong revenue and profitability performance in the fourth quarter and FDA approval for 3.0T MRI compatibilityFourth quarter revenue growth of 12% and full year revenue growth of 14% Fourth quarter net income per diluted share of $4.66; adjusted net income per diluted share of $1.65 Full year net income per diluted share of $4.89; adjusted net income per diluted share of $2.42 Operating cash flow of $52.5 million in the fourth quarter with full year operating cash flow of $117.0 millionMINNEAPOLIS, Feb. 11, 2026 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for...

Q4 2025 product revenue of €240 million and FY 2025 product revenue of €684 million Q4 2025 operating profit of €10 million and cash flow from operating activities of €73 million TransCon® CNP under FDA Priority Review, PDUFA action goal date of February 28, 2026 Conference call today at 4:30 pm ETCOPENHAGEN, Denmark, Feb. 11, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update. “With a continued focus on making a meaningful difference for patients, we believe Ascendis is entering a steep growth phase as we transform into a leading global biopharma company,” said Jan Mikkelsen, President and CEO of Ascendis Pharma. “With strong execution and the power of our TransCon platform, we are positioned...

NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) — AMC Networks Inc. (“AMC Networks” or the “Company”) (NASDAQ: AMCX) today reported financial results for the fourth quarter and full year ended December 31, 2025. AMC Networks Chief Executive Officer Kristin Dolan said: “AMC Networks had a successful 2025. Streaming is now the largest single source of revenue in our domestic segment, a significant milestone and inflection point in the ongoing transformation of our business. We delivered free cash flow(1) well ahead of our previously increased forecast and once again achieved our financial guidance for the year. We look forward to continuing to take advantage of our independence and unique strengths as we drive the company forward during a time of change in our industry.” Operational Highlights:Completed...

Q4 and Full Year 2025 financial report available Paris, February 11, 2026 – Lectra informs its shareholders, in compliance with article 221-4-IV of the General Regulation of the Autorité des marchés financiers, that the Management Discussion and Analysis of Financial Conditions and Results of Operations for the fourth quarter and the full year 2025 is available on the company’s website: www.lectra.com It is also available, upon request, at the company’s headquarters 16-18 rue Chalgrin, 75016 Paris (email: investor.relations@lectra.com)About Lectra At the forefront of innovation since its founding in 1973, Lectra provides industrial intelligence technology solutions – combining software in SaaS mode, cutting equipment, data, and associated services – to players in the fashion, automotive and furniture industries....

2025 results: growth in recurring revenues and operational resilienceRevenues: €506.7 million (-2%)* Recurring revenues (75% of the total): +2%*, including +14%* for SaaS subscription contracts ARR as of December 31: €97.2 million, up +14%* EBITDA before non-recurring items: €79.7 million (-8%)*, representing a margin of 15.7% Security ratio**: 96%, demonstrating the Group’s resilience Free cash flow before non-recurring items: €57.0 million Dividend***: €0.35 per share(*) Like-for-like. (**) Share of annual fixed costs covered by the gross profit generated by recurring revenues. (***) Proposed to the Annual Shareholders’ Meeting of April 29, 2026.  October 1 – December 31 January 1 – December 31  2025 2024 Changes 2025/2024 2025 2024 Changes 2025/2024  (in millions of euros)     Actual Like-for-like (1)     Actual Like-for-like...

 Q4 sales & FY 2025 resultsSequential sales growth improvement in Q4 in all geographiesMeeting or exceeding all full-year objectives Axelerate 2028 implementation and deeper productivity initiatives bearing fruit→ FY 25 sales of €19,414.6m, boosted by organic growth and acquisitionsSame-day sales increased by +2.5% in FY 2025, with improving trends quarter after quarterQ4 sales of €4,881.1m, rose +3.8% on a same-day basis (up +4.7% on an actual-day basis), accelerating sequentially with positive momentum in all regions Continued market share gains boosted by digitalization best-in-class services in key countries including France, US, Canada, Austria and SwedenActive acquisitions strategy contributing for +1.8% to FY 25 sales growth→ FY 25 current adjusted EBITA margin at 6.0% up +10bps versus the 5.9% reported...

Revenue1 growing 18.4% in Q4 and 11.2% in the FY Adj. operating margin1,2 at 16.0% in the FYGroup’s revenue at Euro 28,491 million in the FY, +11.2% at constant exchange rates1, with Q4 at +18.4% North America, EMEA and Asia-Pacific regions all growing double digits in Q4 and FY AI-glasses selling more than 7 million units in the FY, with all the regions and brands contributing Nuance Audio’s year-one closing on a promising tone, now available in 12 markets and 15k doors worldwide Myopia management portfolio +22% in revenue worldwide, US on the blocks for a strong start Adjusted2 operating margin at 16.0% at constant exchange rates1, impacted by US tariffs and AI-glasses Record free cash flow4 at Euro 2.8 billion in the FY, Euro 400 million higher than 2024 Dividend proposed at Euro 4.00, offering a scrip dividend option New long-term...

REGULATED INFORMATIONBrussels, 11 February 2026, 5:55 PMSTRONG FULL-YEAR 2025 RESULTS CONFIRM NEXTENSA’S STRATEGIC COURSENextensa closed the 2025 financial year with strong results, confirming a clear increase in profitability (+€33.8 M) driven by a higher contribution from development activities (+1.8 M), lower financing costs (-9.2 M) and a continued balance sheet strengthening. During 2024 and 2025, Nextensa executed several targeted transactions for a total amount of €360 M. As a direct outcome of this disciplined capital recycling approach, Nextensa reduced its debt ratio from 45.39% to 38.80%, significantly enhancing financial flexibility and strengthening the Group’s capacity to finance the next phase of its development pipeline with the Lake Side project and BEL Towers as key developments. These projects are envisaged to start...

 Q4 sales & FY 2025 resultsSequential sales growth improvement in Q4 in all geographiesMeeting or exceeding all full-year objectives Axelerate 2028 implementation and deeper productivity initiatives bearing fruit→ FY 25 sales of €19,414.6m, boosted by organic growth and acquisitionsSame-day sales increased by +2.5% in FY 2025, with improving trends quarter after quarterQ4 sales of €4,881.1m, rose +3.8% on a same-day basis (up +4.7% on an actual-day basis), accelerating sequentially with positive momentum in all regions Continued market share gains boosted by digitalization best-in-class services in key countries including France, US, Canada, Austria and SwedenActive acquisitions strategy contributing for +1.8% to FY 25 sales growth→ FY 25 current adjusted EBITA margin at 6.0% up +10bps versus the 5.9% reported...